Simone Albani

ORCID: 0000-0002-3560-4539
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Computational Drug Discovery Methods
  • SARS-CoV-2 and COVID-19 Research
  • Protein Structure and Dynamics
  • Monoclonal and Polyclonal Antibodies Research
  • Protein purification and stability
  • Lipid Membrane Structure and Behavior
  • Ion channel regulation and function
  • Chemical Reactions and Isotopes
  • Ion Transport and Channel Regulation
  • vaccines and immunoinformatics approaches
  • Synthesis and biological activity
  • Neuroscience and Neuropharmacology Research
  • Galectins and Cancer Biology
  • Protein Tyrosine Phosphatases
  • Receptor Mechanisms and Signaling
  • Anesthesia and Sedative Agents
  • RNA Interference and Gene Delivery
  • Enzyme Production and Characterization
  • Enzyme Structure and Function
  • Semantic Web and Ontologies
  • RNA and protein synthesis mechanisms
  • Pain Mechanisms and Treatments
  • Mosquito-borne diseases and control
  • Click Chemistry and Applications
  • Bacteriophages and microbial interactions

RWTH Aachen University
2020-2024

Forschungszentrum Jülich
2020-2024

University of Bologna
2023

University of Ferrara
2011

Compound repurposing is an important strategy for the identification of effective treatment options against SARS-CoV-2 infection and COVID-19 disease. In this regard, main protease (3CL-Pro), also termed M-Pro, attractive drug target as it plays a central role in viral replication by processing polyproteins pp1a pp1ab at multiple distinct cleavage sites. We here report results program involving 8.7 K compounds containing marketed drugs, clinical preclinical candidates, small molecules...

10.1021/acsptsci.0c00216 article EN cc-by-nc-nd ACS Pharmacology & Translational Science 2021-03-11

After almost two years from its first evidence, the COVID-19 pandemic continues to afflict people worldwide, highlighting need for multiple antiviral strategies. SARS-CoV-2 main protease (Mpro/3CLpro) is a recognized promising target development of effective drugs. Because single inhibition might not be sufficient block infection and replication, multi enzymatic-based therapies may provide better strategy. Here we present structural biochemical characterization binding mode MG-132 both...

10.3390/ijms222111779 article EN International Journal of Molecular Sciences 2021-10-29

The SARS-CoV-2 coronavirus outbreak continues to spread at a rapid rate worldwide. main protease (Mpro) is an attractive target for anti-COVID-19 agents. Unexpected difficulties have been encountered in the design of specific inhibitors. Here, by analyzing ensemble ∼30 000 Mpro conformations from crystallographic studies and molecular simulations, we show that small structural variations binding site dramatically impact ligand properties. Hence, traditional druggability indices fail...

10.1021/acsptsci.0c00215 article EN cc-by-nc-nd ACS Pharmacology & Translational Science 2021-03-16
Johannes Schimunek Philipp Seidl Katarina Elez Tim Hempel Tuan Anh Le and 95 more Frank Noé Simon Olsson Lluı́s Raich Robin Winter Hatice Gökcan Filipp Gusev Evgeny Gutkin Olexandr Isayev Maria Kurnikova Chamali H. Narangoda R.I. Zubatyuk Ivan P. Bosko Konstantin V. Furs Anna D. Karpenko Yury V. Kornoushenko Mikita Shuldau Artsemi Yushkevich Mohammed Benabderrahmane Patrick Bousquet‐Melou Ronan Bureau Beatrice Charton Bertrand C. Cirou Gérard Gil William J. Allen Suman Sirimulla Stanley J. Watowich Nick Antonopoulos Nikolaos Epitropakis Agamemnon Krasoulis Vassilis Pitsikalis Stavros Theodorakis Igor Kozlovskii Anton Maliutin Alexander Medvedev Petr Popov Mark Zaretckii Hamid Eghbal-zadeh Christina Halmich Sepp Hochreiter Andreas Mayr Peter Ruch Michael Widrich Francois Berenger Ashutosh Kumar Yoshihiro Yamanishi Kam Y. J. Zhang Emmanuel Bengio Yoshua Bengio Moksh Jain Maksym Korablyov Chenghao Liu Gilles Marcou Enrico Glaab Kelly K. Barnsley Suhasini M. Iyengar Mary Jo Ondrechen V. Joachim Haupt Florian Kaiser Michael Schroeder Luisa Pugliese Simone Albani Christina Athanasiou Andrea R. Beccari Paolo Carloni Giulia D’Arrigo Eleonora Gianquinto Jonas Goßen Anton Hanke Benjamin P. Joseph Daria B. Kokh Sandra Kovachka Candida Manelfi Goutam Mukherjee Abraham Muñiz‐Chicharro Francesco Musiani Ariane Nunes‐Alves Giulia Paiardi Giulia Rossetti S. Kashif Sadiq Francesca Spyrakis Carmine Talarico Alexandros Tsengenes Rebecca C. Wade Conner Copeland Jeremiah Gaiser Daniel R. Olson Amitava Roy Vishwesh Venkatraman Travis J. Wheeler Haribabu Arthanari Klara Blaschitz Marco Cespugli Vedat Durmaz Konstantin Fackeldey Patrick D. Fischer

The COVID-19 pandemic continues to pose a substantial threat human lives and is likely do so for years come. Despite the availability of vaccines, searching efficient small-molecule drugs that are widely available, including in low- middle-income countries, an ongoing challenge. In this work, we report results open science community effort, "Billion molecules against challenge", identify inhibitors SARS-CoV-2 or relevant receptors. Participating teams used wide variety computational methods...

10.1002/minf.202300262 article EN cc-by Molecular Informatics 2023-10-14

The 3CL-Protease appears to be a very promising medicinal target develop anti-SARS-CoV-2 agents. availability of resolved structures allows structure-based computational approaches carried out even though the lack known inhibitors prevents proper validation performed simulations. innovative idea study is exploit SARS-CoV 3CL-Pro as training set perform and validate multiple virtual screening campaigns. Docking simulations using four different programs (Fred, Glide, LiGen, PLANTS) were...

10.3390/molecules26040797 article EN cc-by Molecules 2021-02-04

Cholesterol is a major component of plasma membranes and plays significant role in actively regulating the functioning several membrane proteins humans. In this study, we focus on cholesterol depletion voltage-gated sodium channel Na

10.1016/j.ijbiomac.2024.134219 article EN cc-by-nc-nd International Journal of Biological Macromolecules 2024-08-07

The only known peptide-gated ion channels—FaNaCs/WaNaCs and HyNaCs—belong to different clades of the DEG/ENaC family. FaNaCs are activated by short neuropeptide FMRFamide, HyNaCs Hydra RFamides, which not evolutionarily related FMRFamide. FMRFamide-binding site in was recently identified a cleft atop large extracellular domain. However, this is conserved HyNaCs. Here, we combined molecular modeling site-directed mutagenesis putative binding pocket for Hydra-RFamides domain heterotrimeric...

10.1073/pnas.2409097121 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2024-10-04

Many homodimeric enzymes tune their functions by exploiting either negative or positive cooperativity between subunits. In the SARS-CoV-2 Main protease (Mpro) homodimer, latter has been suggested symmetry in most of 500 reported protease/ligand complex structures solved macromolecular crystallography (MX). Here we apply to both covalent and noncovalent ligands with Mpro. Strikingly, our experiments show that occupation active sites dimer originates from an excess ligands. Indeed, cocrystals...

10.1021/acs.jcim.3c01497 article EN cc-by Journal of Chemical Information and Modeling 2023-12-05

Many homodimeric enzymes tune their function by exploiting either negative or positive cooperativity between subunits. In the SARS-CoV-2 Main protease (Mpro) homodimer, latter has been suggested symmetry in most of 500 reported protease/ligand complex structures solved macromolecular crystallography. Here we apply to both covalent and non-covalent ligands with Mpro. Strikingly, our experiments show that occupation active sites dimer originates from an excess ligands. Indeed, co-crystals...

10.26434/chemrxiv-2023-n1x1n preprint EN cc-by 2023-06-02

Abstract Compound repurposing is an important strategy for the identification of effective treatment options against SARS-CoV-2 infection and COVID-19 disease. In this regard, main protease (3CL-Pro), also termed M-Pro, attractive drug target as it plays a central role in viral replication by processing polyproteins pp1a pp1ab at multiple distinct cleavage sites. We here report results program involving 8.7 K compounds containing marketed drugs, clinical preclinical candidates, small...

10.1101/2020.12.16.422677 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2020-12-16

Abstract Cholesterol is a major component of plasma membranes and unsurprisingly plays significant role in actively regulating the functioning several membrane proteins humans. Notably, recent studies have shown that cholesterol depletion can also impact transmission potentially painful signals context peripheral inflammation, via hyperexcitability voltage-gated sodium channel (Na v ) subtype 1.9, but structural mechanisms underlying this regulation remain to be elucidated. In study, we...

10.1101/2024.02.21.581348 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-02-23
Johannes Schimunek Philipp Seidl Katarina Elez Tim Hempel Tuan Anh Le and 95 more Frank Noé Simon Olsson Lluı́s Raich Robin Winter Hatice Gökcan Filipp Gusev Evgeny Gutkin Olexandr Isayev Maria Kurnikova Chamali H. Narangoda R.I. Zubatyuk Ivan P. Bosko Konstantin V. Furs Anna D. Karpenko Yury V. Kornoushenko Mikita Shuldau Artsemi Yushkevich Mohammed Benabderrahmane Patrick Bousquet‐Melou Ronan Bureau Beatrice Charton Bertrand C. Cirou Gérard Gil William J. Allen Suman Sirimulla Stanley J. Watowich Nick A. Antonopoulos Nikolaos Epitropakis Agamemnon K. Krasoulis Vassilis P. Pitsikalis Stavros T. Theodorakis Igor Kozlovskii Anton Maliutin Alexander Medvedev Petr Popov Mark Zaretckii Hamid Eghbal-zadeh Christina Halmich Sepp Hochreiter Andreas Mayr Peter Ruch Michael Widrich Francois Berenger Ashutosh Kumar Yoshihiro Yamanishi Kam Y. J. Zhang Emmanuel Bengio Yoshua Bengio Moksh Jain Maksym Korablyov Chenghao Liu Gilles Marcou Enrico Glaab Kelly K. Barnsley Suhasini M. Iyengar Mary Jo Ondrechen V. Joachim Haupt Florian Kaiser Michael Schroeder Luisa Pugliese Simone Albani Christina Athanasiou Andrea R. Beccari Paolo Carloni Giulia D’Arrigo Eleonora Gianquinto Jonas Goßen Anton Hanke Benjamin P. Joseph Daria B. Kokh Sandra Kovachka Candida Manelfi Goutam Mukherjee Abraham Muñiz‐Chicharro Francesco Musiani Ariane Nunes‐Alves Giulia Paiardi Giulia Rossetti S. Kashif Sadiq Francesca Spyrakis Carmine Talarico Alexandros Tsengenes Rebecca C. Wade Conner Copeland Jeremiah Gaiser Daniel R. Olson Amitava Roy Vishwesh Venkatraman Travis J. Wheeler Haribabu Arthanari Klara Blaschitz Marco Cespugli Vedat Durmaz Konstantin Fackeldey Patrick D. Fischer

The COVID-19 pandemic continues to pose a substantial threat human lives and is likely do so for years come. Despite the availability of vaccines, searching efficient small-molecule drugs that are widely available, including in low- middle-income countries, an ongoing challenge. In this work, we report results community effort, “Billion molecules against Covid-19 challenge”, identify inhibitors SARS-CoV-2 or relevant receptors. Participating teams used wide variety computational methods...

10.26434/chemrxiv-2023-1d5w8 preprint EN cc-by 2023-04-07

Erwinia amylovora is a Gram-negative bacterium, responsible for the fire blight disease in Rosaceae plants. Its virulence correlated with production of an exopolysaccharide (EPS) called amylovoran, which protects bacterium from surrounding environment and helps its diffusion inside host. Amylovoran biosynthesis relies on expression twelve genes clustered ams operon. One these genes, amsI, encodes Low Molecular Weight Protein Tyrosine Phosphatase (LMW-PTP) EaAmsI, plays key role regulation...

10.3390/molecules28237774 article EN cc-by Molecules 2023-11-25

Abstract The SARS-CoV-2 coronavirus outbreak continues to spread at a rapid rate worldwide. main protease (Mpro) is an attractive target for anti-COVID-19 agents. Unfortunately, unexpected difficulties have been encountered in the design of specific inhibitors. Here, by analyzing ensemble ~30,000 Mpro conformations from crystallographic studies and molecular simulations, we show that small structural variations binding site dramatically impact ligand properties. Hence, traditional...

10.1101/2020.12.14.422634 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-12-15
Coming Soon ...